Bronchoscopy Market Size & Share 2025 - 2034

Bronchoscopy Market Size

The global bronchoscopy market size was estimated at USD 3.3 billion in 2024. The market is expected to grow from USD 3.6 billion in 2025 to USD 6.8 billion in 2034, at a CAGR of 7.2% during the forecast period. The market growth is driven by factors such as the increasing incidence of tuberculosis, asthma, lung cancer, and chronic obstructive pulmonary disease (COPD). The introduction of robot-assisted bronchoscopies, growing demand for minimally invasive procedures, and rising geriatric population are also contributing to this growth.

The global market is experiencing significant growth, primarily driven by the increasing prevalence of respiratory diseases such as emphysema, COPD, asthma, and lung cancer. Among these diseases, asthma and COPD are the most prevalent respiratory disease across the world. For instance, as per the World Health Organization (WHO), in 2021, COPD accounted for 5% of deaths worldwide. This data makes it the fourth leading cause of death globally. The primary causes of COPD include long term inhalation of tobacco smoke, chronic asthma, exposure to fumes and dust in the workplace, and both indoor and outdoor pollution.
 

For instance, chronic respiratory conditions such as asthma affected over 339 million people in 2020 (WHO), and it is predicted to rise to 100 million by the year 2025. This drastic rise in the patients with chronic respiratory ailments is leading to an increased supply for bronchoscopy procedures, thus augmenting market growth.
 

In addition, the rising population of elderly people worldwide serves as a key driver for the increased incidence of respiratory disorders. For example, WHO states that 12% of the global population aged 60 and above will increase to 22% by 2050. In addition to this, the National Institutes of Health (NIH) reported that around 10% of the population aged 40 and above globally suffers from COPD. The combination of these conditions along with the increasing elderly population is likely to increase the need for bronchoscopy in the next few years.
 

A bronchoscopy is a therapeutic and minimally invasive diagnostic procedure used to examine the lungs and airways. A bronchoscope, which is a flexible or rigid, thin tube with a light and a camera, is inserted through the mouth or the nose into the bronchi and trachea to get visuals of the respiratory tract.
 

Bronchoscopy Market Trends

• The increasing awareness about hospital-acquired infections (HAIs) therapeutics and its growing incidence is driving the transformation from reusable to disposable single-use bronchoscopes. For instance, according to the WHO, approximately one in ten patients are affected by HAIs, promoting the shift towards the use of disposable instruments and equipment.
   
• Additionally, the introduction of robot-assisted bronchoscopy has significantly boosted accuracy, stability, and better reach in the procedures. For instance, the Ion robotic bronchoscopy platform developed by the Interventional Pulmonology Program at Moffitt Cancer Center uses small catheters and fiber optics to each all areas of the lung.
   

Bronchoscopy Market Analysis

In 2021, the global market was valued at USD 2.6 billion. The following year, it saw a slight increase to USD 2.8 billion, and by 2023, the market further climbed to USD 3.1 billion. Based on product type, the market is segmented into rigid bronchoscopes, flexible bronchoscopes, and other product types. The flexible bronchoscopes segment dominated the market with the largest revenue share of 57.1% in 2024 and is expected to grow at a CAGR of 7.4% over the forecast period.
 

• The integration of HD video, AI, and NBI imaging features into flexible bronchoscopes has significantly enhanced the visualization of lungs and airway structures, as well as have enabled real time diagnosis and image processing.
   
• Furthermore, the growing use of disposable flexible bronchoscopes, together with the guided biopsy procedures performed using the bronchoscope specifically for lymph node and lung cancer staging assessment, is also boosting this segment’s growth.
   

Based on product usage, the bronchoscopy market is bifurcated into single use/disposable and reusable. The single use/disposable segment dominated the market with the largest share of 56.3% in 2024.
 

• The market transition from conventional open surgical procedures to minimally invasive procedures for therapeutic and diagnostic purposes is driving the adoption of single use/disposable bronchoscopes.
   
• Additionally, the increasing incidence of HAIs among the patient population is driving the demand for disposable instruments and equipment. For instance, according to the Centers for Disease Control and Prevention, approximately one out of thirty-one hospital patients is affected by at least one HAI on a given day in the U.S. This high volume of HAIs is driving the demand for disposable bronchoscopes in respiratory disease diagnostic procedures.
   

Based on age group, the bronchoscopy market is bifurcated into adult and pediatric. The adult segment dominated the market with the largest revenue of USD 2.8 billion in 2024 and is expected to grow at a CAGR of 7.3% over the forecast period.
 

• The rising segmental growth can be attributed to an increasing number of respiratory diseases among the world’s adult population. This has further worsened due to COVID-19 and post COVID pulmonary complications. For example, the Centers for Disease Control and Prevention reports states that the prevalence of COPD amongst adults 18 years and older is 3.8% in 2023.
   
• Also, the elderly population is expanding, contributing to a higher risk of airway, infection and lung diseases, which further increases the need for bronchoscopy procedures. For example, the WHO projects that the population aged 80 years and over will increase three times between 2020 and 2050 to reach 426 million.
   

The U.S. bronchoscopy market was valued at USD 770.7 million in 2021.  The country dominated the North American market in 2023 with USD 921.1 million growing from USD 845.1 million in 2022.
 

• The rise in lung cancer cases is likely to boost the need for bronchoscopy procedures in U.S. For example, the American Cancer Society projects that there will be 226,650 new lung cancer diagnoses in the country in 2025.
   
• Furthermore, the presence of Ambu, Boston Scientific Corporation, Cook Medical, and other major market players also strengthens this region’s position in the global market.
   

The bronchoscopy industry in UK is expected to experience significant and promising growth from 2025 to 2034 in the European market.
 

• The UK reports one of the highest numbers of respiratory disease cases due to conditions such as interstitial lung diseases (ILD), asthma, lung cancer, and COPD. For example, the European Respiratory Society estimates that around 585,000 respiratory disease cases are diagnosed in the UK every year, with half of these cases related to asthma and COPD.
   
• The demand for bronchoscopy procedures in the region is further increasing due to government programs offering health checkups and initiatives like lung disease screening programs by organizations such as the National Health Service (NHS).
   

Japan bronchoscopy market is anticipated to witness lucrative growth between 2025 – 2034.
 

• Japan’s aging population leads to the high prevalence of respiratory diseases and thus contributes to the need for bronchoscopy. For instance, the World Health Organization (WHO) indicates that as of 2023, 29.1% of the population in Japan was 65 years or older, which is the highest percentage across all other countries. This implies that there will be sustained growth in the adoption of advanced bronchoscopy procedures in the country.
   
• Furthermore, high adoption of bronchoscopy procedures in Japan is supported by an extensive network of primary care clinics and tertiary hospitals. For example, in 2023, Ubie Health mentioned that Japan had a total of 103,071 clinics and 8,236 hospitals.
   

The bronchoscopy market in Saudi Arabia is expected to experience significant and promising growth from 2025 to 2034.
 

• In Saudi Arabia, the growing aging population, along with high pollution levels and smoking rates is further boosting the prevalence of COPD, asthma, and even lung cancer. For instance, Global Action to End Smoking reports that in 2022, approximately 4.8 million people aged 15 years or older were smokers and tobacco users. This huge population of smokers is increasing the requirement for bronchoscopy and other diagnostic procedures for respiratory diseases.
   
• Moreover, government strategies like Vision 2030 along with programs by relevant organizations such as the Ministry of Health (MOH) are facilitating greater awareness towards early diagnosis of respiratory disorders which in turn creates higher demand for bronchoscopy procedures.
   

Bronchoscopy Market Share

In 2024, Olympus Corporation, Boston Scientific Corporation, CONMED Corporation, Medtronic, and Karl Storz accounted for the largest market share of XX% in the market. The market is competitive and has presence of both established companies and numerous smaller firms. Vendors are majorly focusing on investing in the development of advanced bronchoscopy instruments and procedures, such as robotic-endoscopy devices, machine learning (ML) and artificial intelligence (AI), and endobronchial ultrasound (EBUS), to enhance treatment efficiency.
 

Additionally, vendors are also forming strategic partnerships with research institutions and healthcare providers for the purpose of modernizing technologies and improving the scope of distribution, which has enabled them to meet the increasing need for non-invasive and affordable diagnostic solutions. Additionally, the assistance grants and simplified approval procedures are further propelling the innovation and entry into the market which consolidates the firm’s position in the expanding market.
 

Bronchoscopy Industry News:

• In May 2024, Olympus Corporation announced the launch of two new bronchoscopes that were part of its EVIS X1 Endoscopy System. The bronchoscopes had a slim outer diameter with high-definition imaging allowing for access to distal airways. This launch was expected to expand the reach of the organization in the market.
   
• In July 2020, Ambu announced that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance for its Ambu aScope Duodeno, a single-use, sterile duodenoscope. This launch was expected to bolster the organization’s position in the market and expand its product offerings.
   

Bronchoscopy Market Companies

Some of the eminent market participants operating in the bronchoscopy industry include:

• Ambu
• Boston Scientific Corporation
• Broncus Medical
• Cogentix Medical
• CONMED Corporation
• Cook Medical
• FUJIFILM Holdings America Corporation
• Hoya Corporation
• Johnson & Johnson
• Karl Storz
• Medtronic
• Olympus Corporation
• Richard Wolf
• Teleflex
• Verathon
   
• Ambu, through its single-use imaging and all-in-one capabilities, is a frontrunner in single-use bronchoscopes with the aScope 5 Broncho series, which includes exceptional maneuverability features.
   
• Boston Scientific provides a ready-to-use sterile device for bedside procedures with improved suction capabilities. The design is useful for users accustomed to reusable models.
   
• Johnson & Johnson is one of the key players in the medical devices market and offers a one-of-its-kind, first flexible robotically-assisted bronchoscopy system, the MONARCH Platform.
   

The bronchoscopy market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

• Rigid bronchoscopes
• Flexible bronchoscopes
• Other product types

Market, By Product Usage

• Single use/disposable
• Reusable

Market, By Age Group

• Adult
• Pediatric

The above information is provided for the following regions and countries:

• North America 
  • U.S.
  • Canada
• Europe 
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific 
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America 
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa 
  • South Africa
  • Saudi Arabia
  • UAE